title: Bronchoesophageal fistula and fatal hemoptysis after bevacizumab-containing chemotherapy without radiation in lung cancer.
authors.affiliation: University Hospital Magdeburg, Dept. Pulmonology, Leipziger Str. 44, 39120 Magdeburg, Germany. je-schreiber@t-online.de
authors.forename: Jens
authors.initials: J
authors.lastname: Schreiber
authors.forename: Nadine
authors.initials: N
authors.lastname: Waldburg
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy*; D000077192:Adenocarcinoma of Lung; D000328:Adult; D020533:Angiogenesis Inhibitors / Q000008:administration & dosage / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage / Q000009:adverse effects*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D000068258:Bevacizumab; D001983:Bronchial Fistula / Q000175:diagnosis / Q000209:etiology*; D001999:Bronchoscopy; D016190:Carboplatin / Q000008:administration & dosage; D004937:Esophageal Fistula / Q000175:diagnosis / Q000209:etiology*; D017809:Fatal Outcome; D006469:Hemoptysis / Q000209:etiology*; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D008297:Male; D017239:Paclitaxel / Q000008:administration & dosage; D015607:Stents; D014057:Tomography, X-Ray Computed; D014138:Tracheoesophageal Fistula / Q000209:etiology
chemical_list: D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D016190:Carboplatin; D017239:Paclitaxel